Cardiff Lexington Corp

Cardiff Lexington Corp (ticker: CDIX) is an OTC-listed services-offices & clinics of doctors of medicine company. DredgeCap's structured extraction of CDIX's SEC filings surfaces 40 active risk signals, including 37 late-filing signals, 2 auditor-change signals, and 1 delisting/deregistration signal. CDIX reported $2.22M in revenue and -$3.09M for the period ending 2026-03-31, with operating cash flow of -$17K. Cash and equivalents stood at $684K (down 31.4% year-over-year). Total assets of $30.29M exceed total liabilities of $24.63M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.